Donna Cryer, CEO of CryerHealth: Patient-Centric Solutions, has devoted her career to communicating complex medical, medical/legal, and bioethical issues topics to a variety of crucial audiences, including the media, lawmakers, patients, and medical and legal professionals as well as the general public.
A savvy coalition-builder and grassroots organizer, Ms. Cryer identifies potential supporters and fuses them into powerful instruments for both targeted and mass communications. As a Georgetown-educated attorney, she brings a keen legal as well as communications eye to multicultural marketing, business development, program development, and strategic planning.
A liver transplant recipient, Mrs. Cryer was named to a five-year term as a Patient Representative to the U.S. Food and Drug Administration and elected the first patient to chair the board of the American Liver Foundation. Mrs. Cryer serves as an advisor to the Institute for Patient-Centered Design and has spoken on the topic of E-patients at the National Institutes of Health, American Association for the Advancement of Science, American Academy of Nursing, World Health Innovation and Technology Conference, and Princeton Medical Center.
For Pfizer, Ms. Cryer was a key player on a cross-agency team that represented the company’s cardiovascular franchise (Lipitor, Norvasc, and Caduet). For GlaxoSmithKline, she led the account team responsible for marketing Epivir-HBV in Asian-American markets around the country. For Aventis, Ms. Cryer generated multicultural marketing for diabetes, deep vein thrombosis, and cancer medications. For Johnson & Johnson, she created a policy analysis program to predict and influence regulatory treatment of follow-on biologics.
Mrs. Cryer has been featured on CNN, Fox News, CBS Evening News, and NBC News. She serves on the advisory committee for the Women’s Health Institute at Howard University; the board of the Mid-Atlantic Chapter of the Healthcare Businesswomen’s Association; and is a member of the Women Business Leaders of the U.S. Health Care Industry Foundation, the American Society of Association Executives, and the Virginia State Bar.
1900 M Street, NW
Washington, DC 20036
Two weeks ago, Toyota agreed to a record $1.2 billion settlement with U.S. regulators for the company’s alleged mishandling of its recall during its unintended acceleration crisis. Now it’s General...